CoreCap Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Buy
857
+40
+5% +$19.2K 0.01% 590
2026
Q1
$402K Sell
817
-9
-1% -$4.88K 0.01% 566
2025
Q4
$479K Buy
826
+55
+7% +$31.1K 0.02% 519
2025
Q3
$374K Buy
771
+14
+2% +$6.52K 0.01% 596
2025
Q2
$307K Sell
757
-47
-6% -$19.7K 0.01% 632
2025
Q1
$400K Buy
804
+77
+11% +$41.7K 0.02% 514
2024
Q4
$378K Sell
727
-30
-4% -$16.5K 0.02% 531
2024
Q3
$468K Buy
+757
New +$448K 0.02% 474
2024
Q2
Sell
-637
Closed -$370K 2485
2024
Q1
$370K Buy
637
+103
+19% +$57.8K 0.02% 459
2023
Q4
$283K Buy
534
+2
+0.4% +$968 0.02% 474
2023
Q3
$269K Buy
532
+45
+9% +$24K 0.02% 443
2023
Q2
$254K Buy
+487
New +$263K 0.02% 483
2022
Q4
$377K Buy
685
+7
+1% +$3.71K 0.03% 409
2022
Q3
$344K Buy
678
+16
+2% +$8.95K 0.03% 402
2022
Q2
$360K Sell
662
-57
-8% -$31.4K 0.03% 393
2022
Q1
$425K Sell
719
-141
-16% -$81K 0.03% 348
2021
Q4
$574K Buy
+860
New +$537K 0.04% 334

Other funds holding TMO

CoreCap Advisors's TMO Position: Q2 2026 in Review

CoreCap Advisors increased its Thermo Fisher Scientific (TMO) stake by 4.9% in Q2 2026, buying an estimated $19.2K and bringing the position to 857 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #590.

CoreCap Advisors first reported a position in TMO in Q4 2021 and has held it in 17 quarters since. The position peaked at $574K in Q4 2021. 723 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • CoreCap Advisors held 857 shares of Thermo Fisher Scientific worth $429K as of Q2 2026.
  • CoreCap Advisors bought 40 Thermo Fisher Scientific shares in Q2 2026, an estimated $19.2K.
  • Thermo Fisher Scientific made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #590 holding.
  • CoreCap Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 17 quarters since.
  • CoreCap Advisors's Thermo Fisher Scientific position peaked at $574K in Q4 2021.
  • 723 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.